Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1962 1
1963 2
1964 3
1966 3
1968 6
1969 1
1970 6
1971 8
1972 5
1973 7
1974 9
1975 5
1976 6
1977 2
1978 7
1979 8
1980 10
1981 11
1982 13
1983 14
1984 10
1985 15
1986 17
1987 21
1988 16
1989 20
1990 19
1991 21
1992 21
1993 17
1994 14
1995 13
1996 9
1997 25
1998 28
1999 21
2000 36
2001 39
2002 37
2003 39
2004 35
2005 35
2006 37
2007 19
2008 30
2009 25
2010 39
2011 41
2012 58
2013 53
2014 63
2015 56
2016 64
2017 69
2018 81
2019 94
2020 104
2021 110
2022 128
2023 109
2024 89
2025 77

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,760 results

Results by year

Filters applied: . Clear all
Page 1
Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction-associated steatotic liver disease: A prospective, multicentre, observational study.
Arai T, Atsukawa M, Tsubota A, Oikawa T, Tada T, Matsuura K, Ishikawa T, Abe H, Kato K, Morishita A, Tani J, Okubo T, Nagao M, Iwabu M, Iwakiri K. Arai T, et al. Diabetes Obes Metab. 2024 Nov;26(11):4958-4965. doi: 10.1111/dom.15898. Epub 2024 Sep 2. Diabetes Obes Metab. 2024. PMID: 39223865
[Post-traumatic parkinsonism].
Kobayashi S, Tada T. Kobayashi S, et al. Ryoikibetsu Shokogun Shirizu. 1999;(27 Pt 2):61-2. Ryoikibetsu Shokogun Shirizu. 1999. PMID: 10434591 Review. Japanese. No abstract available.
Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study.
Rossari F, Tada T, Suda G, Shimose S, Kudo M, Yoo C, Cheon J, Finkelmeier F, Lim HY, Presa J, Masi G, Bergamo F, Amadeo E, Vitiello F, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Chon HJ, Himmelsbach V, Iavarone M, Cabibbo G, Montes M, Foschi FG, Vivaldi C, Soldà C, Sho T, Niizeki T, Nishida N, Steup C, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Hiraoka A, Tada F, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Imai M, Kosaka H, Naganuma A, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Persano M, Foti S, Camera S, Stefanini B, Scartozzi M, Cascinu S, Casadei-Gardini A, Rimini M. Rossari F, et al. Liver Cancer. 2024 Apr 10;13(5):522-536. doi: 10.1159/000537915. eCollection 2024 Oct. Liver Cancer. 2024. PMID: 39296620 Free PMC article.
Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients.
Persano M, Rimini M, Tada T, Suda G, Shimose S, Kudo M, Cheon J, Finkelmeier F, Lim HY, Presa J, Masi G, Yoo C, Lonardi S, Tovoli F, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Chon HJ, Himmelsbach V, Niizeki T, Montes M, Vivaldi C, Soldà C, Stefanini B, Hiraoka A, Sho T, Nishida N, Steup C, Iavarone M, Di Costanzo G, Marra F, Tamburini E, Cabibbo G, Foschi FG, Silletta M, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Tada F, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Kosaka H, Naganuma A, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Campani C, Amadeo E, Rossari F, Burgio V, Cascinu S, Scartozzi M, Casadei-Gardini A. Persano M, et al. Eur J Cancer. 2023 Aug;189:112933. doi: 10.1016/j.ejca.2023.05.021. Epub 2023 Jun 1. Eur J Cancer. 2023. PMID: 37385069 Free article.
Low-Gradient Severe Aortic Stenosis: Insights From the CURRENT AS Registry-2.
Taniguchi T, Morimoto T, Takeji Y, Shirai S, Ando K, Tabata H, Yamamoto K, Murai R, Osakada K, Sakamoto H, Tada T, Murata K, Obayashi Y, Amano M, Kitai T, Izumi C, Toyofuku M, Kanamori N, Miyake M, Nakayama H, Izuhara M, Nagao K, Nakatsuma K, Furukawa Y, Inoko M, Kimura M, Ishii M, Usami S, Nakazeki F, Shirotani M, Inuzuka Y, Ono K, Minatoya K, Kimura T; CURRENT AS Registry-2 Investigators. Taniguchi T, et al. JACC Cardiovasc Interv. 2025 Feb 24;18(4):471-487. doi: 10.1016/j.jcin.2024.09.044. Epub 2024 Dec 18. JACC Cardiovasc Interv. 2025. PMID: 39708011
2,2'-Spirobi(1,3-benzodithiole).
Ueda K, Iwamatsu M, Sugimoto T, Tada T, Nishimura KI. Ueda K, et al. Acta Crystallogr C. 2000 Apr 15;56(Pt 4):E160-1. doi: 10.1107/S0108270100003528. Epub 2000 Apr 15. Acta Crystallogr C. 2000. PMID: 15263193
1,760 results